Metropolis Healthcare Ltd. has announced the effective transfer of its External Quality Assessment Services (EQAS) Business Division to its subsidiary, Metropolis Quality Solutions Private Limited (MQSPL). This transaction, effective August 27, 2026, was executed on a slump sale basis for a consideration of INR 1.25 crore, discharged through the issuance of MQSPL equity shares to the parent company.
EQAS Business Division Transfer
Metropolis Healthcare Ltd. has completed the transfer of its External Quality Assessment Services (EQAS) Business Division. This significant operational move, effective from August 27, 2026, sees the division integrated into the company’s subsidiary, Metropolis Quality Solutions Private Limited (MQSPL).
Slump Sale Transaction Details
The transfer was conducted as a slump sale, with a total consideration of INR 1.25 crore. This amount has been settled through the issuance of equity shares of MQSPL to Metropolis Healthcare Ltd., adhering to the terms outlined in the Business Transfer Agreement (BTA). Consequently, MQSPL is now responsible for the operations of the EQAS Division as of the effective date.
Source: BSE
